Molecular mechanisms of tumor vascularization

被引:90
作者
Auguste, P [1 ]
Lemiere, S [1 ]
Larrieu-Lahargue, F [1 ]
Bikfalvi, A [1 ]
机构
[1] Univ Bordeaux 1, Inst Natl Sante & Rech Med EMI 0113, Mol Angiogenesis Lab, F-33405 Talence, France
关键词
tumor vascularization; angiogenesis research; tumor therapy;
D O I
10.1016/j.critrevonc.2004.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor angiogenesis is a fast growing sub-domain of angiogenesis research and tumor biology. Basic mechanisms have been unraveled and many key players identified. For many years, tumor vascularization was explained solely by the ingrowth of new vessels into the tumor from preexisting one's. However, in recent years, additional mechanisms have been recognized. These include angioblasts recruitment, cooption, vasculogenic mimicry and mosaic vessels. These different mechanisms may exist concomitantly in the same tumor or may be selectively involved in a specific tumor type or host environment. In this article, we will review, in depth, these different mechanisms and also discuss some aspects of anti-angiogenic tumor therapy. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 87 条
  • [1] Analysis of mural cell recruitment to tumor vessels
    Abramsson, A
    Berlin, Ö
    Papayan, H
    Paulin, D
    Shani, M
    Betsholtz, C
    [J]. CIRCULATION, 2002, 105 (01) : 112 - 117
  • [2] Molecular targeting of angiogenesis
    Alessi, P
    Ebbinghaus, C
    Neri, D
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2004, 1654 (01): : 39 - 49
  • [3] Auguste P, 2001, CANCER RES, V61, P1717
  • [4] Bello L, 2001, CANCER RES, V61, P7501
  • [5] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    Bergers, G
    Brekken, R
    McMahon, G
    Vu, TH
    Itoh, T
    Tamaki, K
    Tanzawa, K
    Thorpe, P
    Itohara, S
    Werb, Z
    Hanahan, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (10) : 737 - 744
  • [6] Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
    Bergers, G
    Song, S
    Meyer-Morse, N
    Bergsland, E
    Hanahan, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) : 1287 - 1295
  • [7] Molecular classification of cutaneous malignant melanoma by gene expression profiling
    Bittner, M
    Meitzer, P
    Chen, Y
    Jiang, Y
    Seftor, E
    Hendrix, M
    Radmacher, M
    Simon, R
    Yakhini, Z
    Ben-Dor, A
    Sampas, N
    Dougherty, E
    Wang, E
    Marincola, F
    Gooden, C
    Lueders, J
    Glatfelter, A
    Pollock, P
    Carpten, J
    Gillanders, E
    Leja, D
    Dietrich, K
    Beaudry, C
    Berens, M
    Alberts, D
    Sondak, V
    Hayward, N
    Trent, J
    [J]. NATURE, 2000, 406 (6795) : 536 - 540
  • [8] Antiangiogenic therapy and tumor progression
    Blagosklonny, MV
    [J]. CANCER CELL, 2004, 5 (01) : 13 - 17
  • [9] The hypoxic response of tumors is dependent on their microenvironment
    Blouw, B
    Song, HQ
    Tihan, T
    Bosze, J
    Ferrara, N
    Gerber, HP
    Johnson, RS
    Bergers, G
    [J]. CANCER CELL, 2003, 4 (02) : 133 - 146
  • [10] Burri PH, 2002, MOL ASPECTS MED, V23, pS1